Table 5.
Echocardiographic parameters, prevalence of chronic kidney disease and cardiovascular organ damage in study groups.
| LVEDD (mm) | Ao (mm) | LA Diam (mm) | IVS (mm) | PW (mm) | EF (%) | IMT (mm) | FO (%) | Athero (%) | CKD-EPI ml/min | |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP-III (n.222) | 47.8 ± 8.9 | 32.4 ± 4.9 | 22.6 ± 7.7 | 11.3 ± 4.3 | 9.7 ± 2.4 | 56.6 ± 3.5 | 0.83 ± 0.15 | 30.2 | 27.1 | 82.7 ± 22.5 |
| IDF (n.247) | 48.1 ± 4.2 | 33.5 ± 535 | 23.4 ± 7.6 | 11.9 ± 5.8 | 10.0 ± 2.2 | 56.3 ± 3.8 | 0.84 ± 0.14 | 32.8 | 24.3 | 80.2 ± 21.3 |
| CKM 1 (n.66) | 47.6 ± 3.8 | 32.6 ± 4.2 | 21.5 ± 7.9 | 10.8 ± 1.7 | 9.9 ± 3.1 | 57.3 ± 3.1 | 0.79 ± 0.14 | 21.7 | 24.2 | 100.9 ± 6.3 |
| CKM 2 (n.129) | 48.1 ± 3.8 | 33.4 ± 4.9 | 22.4 ± 8.1 | 10.8 ± 2.0 | 9.7 ± 1.7 | 59.3 ± 1.3 | 0.80 ± 0.13 | 31.6 | 16.4 | 85.5 ± 16.9 |
| CKM 3 (n.105) | 47.2 ± 4.4 | 32.7 ± 4.8 | 23.3 ± 6.1 | 11.4 ± 1.9 | 9.8 ± 1.4 | 54.9 ± 1.2 | 0.83 ± 0.14 | 37.8*** | 26.1 | 78.5 ± 23 |
| CKM 4 (n.14) | 51.0 ± 1.4 | 36 ± 10**** | 29.8 ± 9.8 | 12 ± 2.1**** | 15.3 ± 8**** | 48 ± 13.1**** | 0.85 ± 0.24 | 47.3*** | 25 | 38.8 ± 34**** |
| p-value | ns | ****p < 0.05 vs. IDF | ns | ****p < 0.05 vs. ATP-III, IDF, CKM 1-2-3 | ****p < 0.05 vs. ATP-III, IDF, CKM 1-2-3 | ****p < 0.05 vs. ATP-III, IDF, CKM 1,2,3 | ns | ****p < 0.05 vs. ATP-III, IDF, CKM 1,2 | ns | ****p < 0.05 vs. TP-III, IDF, CKM 1,2,3 |
LVEDD, left ventricular end-diastolic diameter; Ao, aortic diameter; LA Diam, left atrium diameter; IVS, interventricular septum; PW, posterior wall; EF, ejection fraction; IMT, intima-media thickness; FO, altered fundus oculi findings; Athero, atherosclerotic plaque; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration.
****Group with statistically significant difference.